• ๐—›๐—ผ๐˜„ ๐—Ÿ๐—ฒ๐—ฎ๐—ฑ๐—ถ๐—ป๐—ด ๐—–๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€ ๐—”๐—ฟ๐—ฒ ๐—ฆ๐—ต๐—ฎ๐—ฝ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—•๐—น๐—ผ๐—ผ๐—ฑ ๐—š๐—ฎ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—˜๐—น๐—ฒ๐—ฐ๐˜๐—ฟ๐—ผ๐—น๐˜†๐˜๐—ฒ ๐—”๐—ป๐—ฎ๐—น๐˜†๐˜‡๐—ฒ๐—ฟ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜

    According to Next Move Strategy Consulting, the global blood gas and electrolyte analyzer market size was valued at USD 2.19 billion in 2023, and is expected to reach USD 3.50 billion in 2030 with a CAGR of 5.8% from 2024 to 2030 as per the anal due to the growing geriatric population. This significant growth is primarily driven by the increasing geriatric population, coupled with the rising prevalence of chronic diseases and the growing demand for point-of-care testing. As healthcare systems globally prioritize patient-centric care, the demand for accurate and efficient diagnostic tools continues to rise.
    ๐—›๐—ผ๐˜„ ๐—Ÿ๐—ฒ๐—ฎ๐—ฑ๐—ถ๐—ป๐—ด ๐—–๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€ ๐—”๐—ฟ๐—ฒ ๐—ฆ๐—ต๐—ฎ๐—ฝ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—•๐—น๐—ผ๐—ผ๐—ฑ ๐—š๐—ฎ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—˜๐—น๐—ฒ๐—ฐ๐˜๐—ฟ๐—ผ๐—น๐˜†๐˜๐—ฒ ๐—”๐—ป๐—ฎ๐—น๐˜†๐˜‡๐—ฒ๐—ฟ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ According to Next Move Strategy Consulting, the global blood gas and electrolyte analyzer market size was valued at USD 2.19 billion in 2023, and is expected to reach USD 3.50 billion in 2030 with a CAGR of 5.8% from 2024 to 2030 as per the anal due to the growing geriatric population. This significant growth is primarily driven by the increasing geriatric population, coupled with the rising prevalence of chronic diseases and the growing demand for point-of-care testing. As healthcare systems globally prioritize patient-centric care, the demand for accurate and efficient diagnostic tools continues to rise.
    WWW.NEXTMSC.COM
    Impact of Companies on Blood Gas Analyzer Market
    Explore how companies influence the blood gas and electrolyte analyzer market through innovation, collaboration, and strategic development.
    0 Kommentare 0 Anteile 155 Ansichten 0 Vorschau
  • ๐—˜๐˜…๐—ฝ๐—น๐—ผ๐—ฟ๐—ถ๐—ป๐—ด ๐—›๐—ผ๐˜„ ๐——๐—ฒ๐—ป๐˜๐˜€๐—ฝ๐—น๐˜† ๐—ฆ๐—ถ๐—ฟ๐—ผ๐—ป๐—ฎ, ๐—ฃ๐—ต๐—ถ๐—น๐—ถ๐—ฝ๐˜€, ๐—ฎ๐—ป๐—ฑ ๐—ฉ๐—ฎ๐˜๐—ฒ๐—ฐ๐—ต ๐—Ÿ๐—ฒ๐—ฎ๐—ฑ ๐˜๐—ต๐—ฒ ๐—–๐—•๐—–๐—ง ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐˜„๐—ถ๐˜๐—ต ๐Ÿฐ๐Ÿฑ% ๐—–๐—ผ๐—ป๐˜๐—ฟ๐—ผ๐—น

    Next Move Strategy Consulting predicts a significant growth of more than two-fold in the global Cone Beam Computed Tomography (CBCT) Systems Market by 2030. The market, valued at USD 1.59 billion in 2023, is expected to reach USD 3.45 billion by 2030. This growth is driven by the rising incidence of oral diseases such as dental caries and oral infections. Additionally, the expanding geriatric population worldwide and the increasing application of CBCT systems in various medical conditions, including orthopedics, lung cancer, and brain tumors, are further propelling the market.
    ๐—˜๐˜…๐—ฝ๐—น๐—ผ๐—ฟ๐—ถ๐—ป๐—ด ๐—›๐—ผ๐˜„ ๐——๐—ฒ๐—ป๐˜๐˜€๐—ฝ๐—น๐˜† ๐—ฆ๐—ถ๐—ฟ๐—ผ๐—ป๐—ฎ, ๐—ฃ๐—ต๐—ถ๐—น๐—ถ๐—ฝ๐˜€, ๐—ฎ๐—ป๐—ฑ ๐—ฉ๐—ฎ๐˜๐—ฒ๐—ฐ๐—ต ๐—Ÿ๐—ฒ๐—ฎ๐—ฑ ๐˜๐—ต๐—ฒ ๐—–๐—•๐—–๐—ง ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐˜„๐—ถ๐˜๐—ต ๐Ÿฐ๐Ÿฑ% ๐—–๐—ผ๐—ป๐˜๐—ฟ๐—ผ๐—น Next Move Strategy Consulting predicts a significant growth of more than two-fold in the global Cone Beam Computed Tomography (CBCT) Systems Market by 2030. The market, valued at USD 1.59 billion in 2023, is expected to reach USD 3.45 billion by 2030. This growth is driven by the rising incidence of oral diseases such as dental caries and oral infections. Additionally, the expanding geriatric population worldwide and the increasing application of CBCT systems in various medical conditions, including orthopedics, lung cancer, and brain tumors, are further propelling the market.
    WWW.NEXTMSC.COM
    Dentsply, Philips, Vatech Lead CBCT Industry with 45%+ Share
    Explore the growing CBCT systems market, highlighting trends, innovations, and key players in dental and medical imaging.
    0 Kommentare 0 Anteile 160 Ansichten 0 Vorschau
  • ๐…๐ข๐ง๐ฅ๐š๐ง๐ ๐„๐š๐ซ๐ฅ๐ฒ ๐“๐จ๐ฑ๐ข๐œ๐ข๐ญ๐ฒ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐š๐ง๐ ๐๐ž๐ง๐œ๐ก๐ฆ๐š๐ซ๐ค๐ข๐ง๐ 

    ๐…๐ข๐ง๐ฅ๐š๐ง๐ ๐„๐š๐ซ๐ฅ๐ฒ ๐“๐จ๐ฑ๐ข๐œ๐ข๐ญ๐ฒ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ is predicted to reach USD 33.29 million
    with a CAGR of 20.8% till 2030. The surging demand for early toxicity testing in Finland can be attributed to several significant factors, prominently driven by the expanding geriatric population.

    ๐Š๐ž๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ:

    ๐‚๐จ๐ง๐ฌ๐ฎ๐ฆ๐ž๐ซ ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐š๐ง๐ ๐๐ซ๐ž๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž๐ฌ : Danish consumers are increasingly conscious of the safety and environmental impact of the products they use. This shift in consumer behaviour is driving companies to adopt comprehensive toxicity testing practices to ensure their products are safe and eco-friendly. This is particularly evident in the cosmetics, personal care, and food industries.

    ๐…๐จ๐œ๐ฎ๐ฌ ๐จ๐ง ๐๐š๐ญ๐ฎ๐ซ๐š๐ฅ ๐š๐ง๐ ๐Ž๐ซ๐ ๐š๐ง๐ข๐œ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ : The demand for natural and organic products is growing in Denmark, particularly in cosmetics and personal care. To meet consumer expectations and regulatory standards, companies are investing in early toxicity testing to ensure that these products are safe, effective, and free from harmful chemicals.

    ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐’๐š๐Ÿ๐ž๐ญ๐ฒ : Denmark is home to a strong pharmaceutical and biotechnology industry, and early toxicity testing is crucial for the development of new drugs and therapies. Companies are leveraging toxicity testing to identify adverse effects before clinical trials, improving patient safety and reducing time-to-market for new medications.

    https://www.nextmsc.com/report/finland-early-toxicity-testing-market
    ๐…๐ข๐ง๐ฅ๐š๐ง๐ ๐„๐š๐ซ๐ฅ๐ฒ ๐“๐จ๐ฑ๐ข๐œ๐ข๐ญ๐ฒ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐š๐ง๐ ๐๐ž๐ง๐œ๐ก๐ฆ๐š๐ซ๐ค๐ข๐ง๐  ๐…๐ข๐ง๐ฅ๐š๐ง๐ ๐„๐š๐ซ๐ฅ๐ฒ ๐“๐จ๐ฑ๐ข๐œ๐ข๐ญ๐ฒ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ is predicted to reach USD 33.29 million with a CAGR of 20.8% till 2030. The surging demand for early toxicity testing in Finland can be attributed to several significant factors, prominently driven by the expanding geriatric population. ๐Š๐ž๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ: ๐‚๐จ๐ง๐ฌ๐ฎ๐ฆ๐ž๐ซ ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐š๐ง๐ ๐๐ซ๐ž๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž๐ฌ : Danish consumers are increasingly conscious of the safety and environmental impact of the products they use. This shift in consumer behaviour is driving companies to adopt comprehensive toxicity testing practices to ensure their products are safe and eco-friendly. This is particularly evident in the cosmetics, personal care, and food industries. ๐…๐จ๐œ๐ฎ๐ฌ ๐จ๐ง ๐๐š๐ญ๐ฎ๐ซ๐š๐ฅ ๐š๐ง๐ ๐Ž๐ซ๐ ๐š๐ง๐ข๐œ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ : The demand for natural and organic products is growing in Denmark, particularly in cosmetics and personal care. To meet consumer expectations and regulatory standards, companies are investing in early toxicity testing to ensure that these products are safe, effective, and free from harmful chemicals. ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐’๐š๐Ÿ๐ž๐ญ๐ฒ : Denmark is home to a strong pharmaceutical and biotechnology industry, and early toxicity testing is crucial for the development of new drugs and therapies. Companies are leveraging toxicity testing to identify adverse effects before clinical trials, improving patient safety and reducing time-to-market for new medications. https://www.nextmsc.com/report/finland-early-toxicity-testing-market
    WWW.NEXTMSC.COM
    Finland Early Toxicity Testing Market Analysis | 2023-2030
    Finland Early Toxicity Testing Market is predicted to reach $33.29 million by 2030 with a CAGR of 20.8% from 2023 to 2030
    0 Kommentare 0 Anteile 441 Ansichten 0 Vorschau
  • ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐”๐Š ๐„๐š๐ซ๐ฅ๐ฒ ๐“๐จ๐ฑ๐ข๐œ๐ข๐ญ๐ฒ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ

    ๐”๐Š ๐„๐š๐ซ๐ฅ๐ฒ ๐“๐จ๐ฑ๐ข๐œ๐ข๐ญ๐ฒ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ is predicted to reach USD 289.77 million with a CAGR of 6.73% till 2030.The expanding geriatric population in the UK is emerging as a significant catalyst driving the growth of the early toxicity testing market.

    ๐Š๐ž๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ:

    ๐‡๐ฎ๐ฆ๐š๐ง-๐‘๐ž๐ฅ๐ž๐ฏ๐š๐ง๐ญ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  : The use of 3D cell cultures, organ-on-chip technologies, and microfluidics has become more prevalent, as these models provide more accurate predictions of human toxicity than traditional 2D cell cultures. This shift is driven by the need for human-relevant data to improve the safety of new products and reduce the reliance on animal testing.

    ๐€๐ˆ-๐ƒ๐ซ๐ข๐ฏ๐ž๐ง ๐“๐จ๐ฑ๐ข๐œ๐ข๐ญ๐ฒ ๐๐ซ๐ž๐๐ข๐œ๐ญ๐ข๐จ๐ง : The integration of artificial intelligence (AI) and machine learning (ML) is a transformative trend in early toxicity testing. AI algorithms are increasingly used to analyse large datasets, including those from high-throughput screening (HTS), genomics, and proteomics, to predict the toxicity of chemical compounds and pharmaceuticals.

    https://www.nextmsc.com/report/uk-early-toxicity-testing-market
    ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐”๐Š ๐„๐š๐ซ๐ฅ๐ฒ ๐“๐จ๐ฑ๐ข๐œ๐ข๐ญ๐ฒ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐”๐Š ๐„๐š๐ซ๐ฅ๐ฒ ๐“๐จ๐ฑ๐ข๐œ๐ข๐ญ๐ฒ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ is predicted to reach USD 289.77 million with a CAGR of 6.73% till 2030.The expanding geriatric population in the UK is emerging as a significant catalyst driving the growth of the early toxicity testing market. ๐Š๐ž๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ: ๐‡๐ฎ๐ฆ๐š๐ง-๐‘๐ž๐ฅ๐ž๐ฏ๐š๐ง๐ญ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  : The use of 3D cell cultures, organ-on-chip technologies, and microfluidics has become more prevalent, as these models provide more accurate predictions of human toxicity than traditional 2D cell cultures. This shift is driven by the need for human-relevant data to improve the safety of new products and reduce the reliance on animal testing. ๐€๐ˆ-๐ƒ๐ซ๐ข๐ฏ๐ž๐ง ๐“๐จ๐ฑ๐ข๐œ๐ข๐ญ๐ฒ ๐๐ซ๐ž๐๐ข๐œ๐ญ๐ข๐จ๐ง : The integration of artificial intelligence (AI) and machine learning (ML) is a transformative trend in early toxicity testing. AI algorithms are increasingly used to analyse large datasets, including those from high-throughput screening (HTS), genomics, and proteomics, to predict the toxicity of chemical compounds and pharmaceuticals. https://www.nextmsc.com/report/uk-early-toxicity-testing-market
    WWW.NEXTMSC.COM
    UK Early Toxicity Testing Market Share & Analysis | 2023-2030
    UK Early Toxicity Testing Market is predicted to reach $289.77 million by 2030 with a CAGR of 6.73% from 2023 to 2030
    0 Kommentare 0 Anteile 393 Ansichten 0 Vorschau
  • Bioprosthetics Market Dynamics and Competitive Landscape

    The Bioprosthetics Market size is predicted to reach USD 12.36 billion with a CAGR of 10.85% till 2030.

    Demand for bioprosthetics is increasing, owing to rise in prevalence of the geriatric population with cardiovascular disorders such as coronary & peripheral artery diseases and rheumatoid heart disease.

    Bioprosthetics Market Dynamics and Competitive Landscape The Bioprosthetics Market size is predicted to reach USD 12.36 billion with a CAGR of 10.85% till 2030. Demand for bioprosthetics is increasing, owing to rise in prevalence of the geriatric population with cardiovascular disorders such as coronary & peripheral artery diseases and rheumatoid heart disease.
    WWW.NEXTMSC.COM
    Bioprosthetics Market??Statistical Analysis - 2030 | NMSC
    Bioprosthetics Market size is predicted to reach USD 12.36 billion by 2030 with a CAGR 10.85% from 2023-2030.
    0 Kommentare 0 Anteile 262 Ansichten 0 Vorschau
  • The polymer foam market size was valued at USD 114.88 billion in 2019. It is projected to grow to touch USD 157.63 billion by 2027 at a CAGR of 7.73% during the forecast period. The market is thriving at an exponential rate due to its excellent properties in manufacturing of flooring products and insulation panels. Fortune Business Insightsโ„ข stated this in a report titled, "Polymer Foam Market, 2021-2028."



    IInformation Source- https://www.fortunebusinessinsights.com/industry-reports/polymer-foam-market-101698

    Segmentation-

    Growing Demand for Bedding ProductsSpurs PolyurethaneSegment

    On the basis of type, the market is classified into polyethylene (PE), polyvinyl chloride (PVC), polyurethane (PU), polystyrene (PS), and others. The polyurethane segment will dominate due to increasing demand for bedding products and viscoelastic foam for making mattresses.

    Rise in Residential Constructional Activities Surge demand in Building & ConstructionSegment

    In terms of application, the market is categorized into packaging, furniture, appliances, automotive, building & construction, and apparel. The building & construction segment will gain traction due to a rise in residential constructional activities to make building designs classier.

    Report Coverage

    The report provides insights into the regional analysis covering different regions, contributing to the market's growth. The report includes qualitative and quantitative analysis of several factors, such as the key drivers and restraints that will impact the market. Adopting strategies by major players to introduce partnerships, collaboration, and new products will contribute to the market's growth.

    Drivers and Restraints

    Increasing Stress Level among the Students and Working Classto Stimulate Product Demand

    The rise in the global geriatric population has surged a demand for memory foam-based bedding products such as cushions and mattresses. Another reason that surged the need for the product is the increasing stress level among the students and working-class individuals to relax the muscles strain. Meanwhile, due to its non-biodegradable nature, it could hamper the polymer foam market growth.

    Regional Insights

    Growing Awareness about Energy Security Nurtures Growth in North America

    Asia Pacific held the significant polymer foam market share and is expected to lead the global market during the projection period due to the increased disposable income and rising demand from various applications such as construction and packaging.

    Europe has projected remarkable growth across regions during the forecast period due to the growing demand for the product in furniture and packaging applications for better interior design.

    The Middle East & Africa is expected to contribute to sluggish growth due to the lack of production of foams across the regions to meet the local demand.

    Competitive Landscape

    Partnerships among Renowned Companies to Grow Its Client Base

    Leading companies will likely invest in R&D activities, technological advancements, and product rollouts to expand their geographical presence. With soaring investments in innovation and advanced design, stakeholders could inject funds into mergers and acquisitions.

    Industry Developments:

    March 2019: Sika AG acquired Belineco LLC with an aim to develop and manufacture polyurethane foams to grow its client base.

    List of the Companies Profiled in the Polymer Foam Market:

    Synthos (Poland)
    Sekisui Alveo (Switzerland)
    KANEKA CORPORATION (Japan)
    Toray (Japan)
    BASF SE (Germany)
    Sealed Air (U.S.)
    Arkema (France)
    Armacell International S.A. (Germany)
    The polymer foam market size was valued at USD 114.88 billion in 2019. It is projected to grow to touch USD 157.63 billion by 2027 at a CAGR of 7.73% during the forecast period. The market is thriving at an exponential rate due to its excellent properties in manufacturing of flooring products and insulation panels. Fortune Business Insights™ stated this in a report titled, "Polymer Foam Market, 2021-2028." IInformation Source- https://www.fortunebusinessinsights.com/industry-reports/polymer-foam-market-101698 Segmentation- Growing Demand for Bedding ProductsSpurs PolyurethaneSegment On the basis of type, the market is classified into polyethylene (PE), polyvinyl chloride (PVC), polyurethane (PU), polystyrene (PS), and others. The polyurethane segment will dominate due to increasing demand for bedding products and viscoelastic foam for making mattresses. Rise in Residential Constructional Activities Surge demand in Building & ConstructionSegment In terms of application, the market is categorized into packaging, furniture, appliances, automotive, building & construction, and apparel. The building & construction segment will gain traction due to a rise in residential constructional activities to make building designs classier. Report Coverage The report provides insights into the regional analysis covering different regions, contributing to the market's growth. The report includes qualitative and quantitative analysis of several factors, such as the key drivers and restraints that will impact the market. Adopting strategies by major players to introduce partnerships, collaboration, and new products will contribute to the market's growth. Drivers and Restraints Increasing Stress Level among the Students and Working Classto Stimulate Product Demand The rise in the global geriatric population has surged a demand for memory foam-based bedding products such as cushions and mattresses. Another reason that surged the need for the product is the increasing stress level among the students and working-class individuals to relax the muscles strain. Meanwhile, due to its non-biodegradable nature, it could hamper the polymer foam market growth. Regional Insights Growing Awareness about Energy Security Nurtures Growth in North America Asia Pacific held the significant polymer foam market share and is expected to lead the global market during the projection period due to the increased disposable income and rising demand from various applications such as construction and packaging. Europe has projected remarkable growth across regions during the forecast period due to the growing demand for the product in furniture and packaging applications for better interior design. The Middle East & Africa is expected to contribute to sluggish growth due to the lack of production of foams across the regions to meet the local demand. Competitive Landscape Partnerships among Renowned Companies to Grow Its Client Base Leading companies will likely invest in R&D activities, technological advancements, and product rollouts to expand their geographical presence. With soaring investments in innovation and advanced design, stakeholders could inject funds into mergers and acquisitions. Industry Developments: March 2019: Sika AG acquired Belineco LLC with an aim to develop and manufacture polyurethane foams to grow its client base. List of the Companies Profiled in the Polymer Foam Market: Synthos (Poland) Sekisui Alveo (Switzerland) KANEKA CORPORATION (Japan) Toray (Japan) BASF SE (Germany) Sealed Air (U.S.) Arkema (France) Armacell International S.A. (Germany)
    WWW.FORTUNEBUSINESSINSIGHTS.COM
    Polymer Foam Market Size | Global Industry Forecast [2020-2027]
    The global polymer foam market size was $114.88 billion in 2019 & it is projected to reach $157.63 billion by 2027, exhibiting a CAGR of 7.73% in forecast period
    0 Kommentare 0 Anteile 18KB Ansichten 0 Vorschau
Gesponsert